Faes Farma is a Spanish pharmaceutical company known for proprietary specialty medicines, notably bilastine, a second-generation antihistamine marketed widely for allergic rhinitis and urticaria. Its portfolio also includes products such as calcifediol for vitamin D deficiency and other therapeutic lines sold directly and through international licensing partners. The business mixes domestic commercial strength with global out-licensing of key molecules.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 232.5 | — | 53 | — |
| Q4 2025 | 314.3 | 35.2% | 27.3 | -48.5% |
All markets — KeepWinning global stock screener
Other companies on Bolsa de Madrid: Castellana Properties Socimi, S.A. (YCPS), GMP Property SOCIMI, S.A. (YGMP), Atresmedia Corporación de Medios de Comunicación, S.A. (A3M), Cox Infrastructure Group, S.A. (COXG), Prosegur Cash, S.A. (CASH), Aedas Homes, S.A. (AEDAS)